Drawing for GUIDEPOINT

USPTO serial 86232802

GUIDEPOINT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MARESCA, MEREDITH Z
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GUIDEPOINT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roberta Jacobs-Meadway

Roberta Jacobs-Meadway Eckert Seamans Cherin & Mellott L.L.C.50 South 16th StreetPhiladelphia, PA 19102-2516UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005CHEMICAL REAGENTS FOR MEDICAL DIAGNOSTIC PURPOSESACTIVE—
010MEDICAL EQUIPMENT TO DEVELOP CHEMICAL REAGENTS FOR MEDICAL PURPOSES, AND TO GENERATE DIAGNOSTIC TEST RESULTS FOR THE DETERMINATION OF CHRONIC AND ACUTE DISEASES, DRUGS OF ABUSE TESTING, VITAMIN DEFICIENCIES AND THERAPEUTIC DRUG MONITORINGACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 31, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 30, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 11, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 11, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 29, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 27, 2015EX1GSOU EXTENSION 1 GRANTED—
Oct 27, 2015EXT1SOU EXTENSION 1 FILED—
Oct 27, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 28, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 4, 2015NPUBNOTICE OF PUBLICATION—
Mar 3, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 11, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 23, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 22, 2015ALIEASSIGNED TO LIE—
Jan 2, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 29, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 29, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 29, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2014ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 22, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 1, 2014GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 1, 2014GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 1, 2014CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 24, 2014DOCKASSIGNED TO EXAMINER—
Apr 9, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Apr 8, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 29, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance